Senior Director - Patient Advocacy

Select how often (in days) to receive an alert:
Create Alert

The Senior Director – Patient Advocacy is responsible for developing and leading Pharming’s patient advocacy strategy and building strategic partnerships with patient advocacy organizations, rare and ultra-rare disease communities, patients, caregivers, and other relevant stakeholders in support of Pharming’s existing and pipeline therapies across.

This leader will ensure that patient and caregiver perspectives, experiences, and unmet needs are appropriately incorporated into organizational decision-making and will serve as a key internal resource on the rare disease patient journey. Working cross-functionally, this leader will translate patient insights into meaningful strategies and initiatives across Clinical Development, Medical Affairs, Market Access, Marketing, Commercial, and patient support activities.

Additionally, this position is accountable for establishing the goals, objectives, and performance oversight of the field-based APDS Clinical Education (ACE) Team, in conjunction with Pharming’s designated external partner, to support the APDS patient and caregiver community.

Patient Advocacy Strategy & Engagement:

• Lead the development and execution of Pharming’s short- and long-term patient advocacy and engagement strategy, building sustained partnerships with key patient advocacy organizations and strengthening Pharming’s reputation as a valued patient-centric partner.
• Serve as an internal subject matter expert on patient and caregiver perspectives and the rare disease patient journey, ensuring relevant insights are appropriately incorporated into organizational strategy and decision-making.
• Establish and maintain strategic partnerships with national, regional, and global patient advocacy organizations, patient leaders, caregivers, rare disease organizations, and other relevant external stakeholders.
• Identify unmet needs and barriers across the patient journey, including diagnosis, disease burden, treatment access, adherence, caregiver burden, and quality of life, and partner cross-functionally to identify appropriate opportunities to address those needs.
• Partner with advocacy organizations and other stakeholders on education and awareness initiatives that support rare disease research, patient-focused drug development, disease awareness, diagnosis, treatment access, and patient and caregiver support.

Patient Insights &

Cross-Functional Collaboration:

• Develop a structured approach to gathering, synthesizing, and communicating insights from patients, caregivers, advocacy organizations, advisory boards, conferences, and other appropriate engagement activities.
• Translate patient and caregiver insights into actionable recommendations that inform Clinical Development, Medical Affairs, Market Access, Marketing, Commercial strategy, patient support programs, disease education, and lifecycle planning.
• Lead patient advisory boards and other insight-generation activities to better understand the patient experience, unmet needs, treatment expectations, and barriers to care.
• Collaborate with Clinical Development and Medical Affairs to appropriately incorporate patient perspectives into clinical development programs, including trial design, recruitment and retention considerations, patient communications, and disease education.
• Provide patient and advocacy community perspectives to support pipeline development, launch readiness, and lifecycle planning for Pharming’s current and future rare and ultra-rare disease programs.

Advocacy Partnerships & External Leadership:

• Drive sustained engagement with key patient advocacy organizations, including the Immune Deficiency Foundation, Jeffrey Modell Foundation, Hereditary Angioedema…